These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22474621)

  • 21. Systematic Review: Are the Elderly With Diabetes Mellitus Type 2 Prone to Fragility Fractures?
    Papaioannou I; Pantazidou G; Kokkalis Z; Georgopoulos N; Jelastopulu E
    Cureus; 2021 Apr; 13(4):e14514. PubMed ID: 34007765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microstructural and Strength Changes in Trabecular Bone in Elderly Patients with Type 2 Diabetes Mellitus.
    Giner M; Miranda C; Vázquez-Gámez MA; Altea-Manzano P; Miranda MJ; Casado-Díaz A; Pérez-Cano R; Montoya-García MJ
    Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33806850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rethinking Fragility Fractures in Type 2 Diabetes: The Link between Hyperinsulinaemia and Osteofragilitas.
    Cooper ID; Brookler KH; Crofts CAP
    Biomedicines; 2021 Sep; 9(9):. PubMed ID: 34572351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetes Mellitus-induced Bone Fragility.
    Kanazawa I; Sugimoto T
    Intern Med; 2018 Oct; 57(19):2773-2785. PubMed ID: 29780142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on type 2 diabetes-related osteoporosis.
    Wongdee K; Charoenphandhu N
    World J Diabetes; 2015 Jun; 6(5):673-8. PubMed ID: 26069716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Diabetes on Bone Material Properties.
    Lekkala S; Taylor EA; Hunt HB; Donnelly E
    Curr Osteoporos Rep; 2019 Dec; 17(6):455-464. PubMed ID: 31713179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The risks of sarcopenia, falls and fractures in patients with type 2 diabetes mellitus.
    Sarodnik C; Bours SPG; Schaper NC; van den Bergh JP; van Geel TACM
    Maturitas; 2018 Mar; 109():70-77. PubMed ID: 29452785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus.
    Blevins TC; Farooki A
    Postgrad Med; 2017 Jan; 129(1):159-168. PubMed ID: 27894216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of advanced glycation end products (AGEs) in osteoporosis in diabetes.
    Yamagishi S
    Curr Drug Targets; 2011 Dec; 12(14):2096-102. PubMed ID: 22023404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Bone Mineral Density on the Incidence of Age-Related Vertebral Fragility Fracture.
    Lee J; Chang G; Kang H; Ham DW; Lee JS; Jung HS; Song KS
    J Korean Med Sci; 2020 May; 35(17):e116. PubMed ID: 32356418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. OSTEOPOROSIS AND FRACTURE RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS.
    Poiana C; Capatina C
    Acta Endocrinol (Buchar); 2019; 15(2):231-236. PubMed ID: 31508182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone tissue material composition is compromised in premenopausal women with Type 2 diabetes.
    Rokidi S; Andrade VFC; Borba V; Shane E; Cohen A; Zwerina J; Paschalis EP; Moreira CA
    Bone; 2020 Dec; 141():115634. PubMed ID: 32927103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discordance between Prevalent Vertebral Fracture and Vertebral Strength Estimated by the Finite Element Method Based on Quantitative Computed Tomography in Patients with Type 2 Diabetes Mellitus.
    Kiyohara N; Yamamoto M; Sugimoto T
    PLoS One; 2015; 10(12):e0144496. PubMed ID: 26642210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathophysiology and Management of Type 2 Diabetes Mellitus Bone Fragility.
    Eller-Vainicher C; Cairoli E; Grassi G; Grassi F; Catalano A; Merlotti D; Falchetti A; Gaudio A; Chiodini I; Gennari L
    J Diabetes Res; 2020; 2020():7608964. PubMed ID: 32566682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low serum level of the endogenous secretory receptor for advanced glycation end products (esRAGE) is a risk factor for prevalent vertebral fractures independent of bone mineral density in patients with type 2 diabetes.
    Yamamoto M; Yamaguchi T; Yamauchi M; Sugimoto T
    Diabetes Care; 2009 Dec; 32(12):2263-8. PubMed ID: 19752174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incident Fracture Risk in Type 2 Diabetic Postmenopausal Women in Mainland China: Peking Vertebral Fracture Study.
    Jiajue R; Qi X; Jiang Y; Wang Q; Wang W; Pei Y; Wang X; Huang W; Zheng X; Ning Z; Wang O; Li M; Xing X; Yu W; Xu L; Xia W
    Calcif Tissue Int; 2019 Nov; 105(5):466-475. PubMed ID: 31511960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes and bone fragility: a dangerous liaison.
    Conti F; Wolosinska DT; Pugliese G
    Aging Clin Exp Res; 2013 Oct; 25 Suppl 1():S39-41. PubMed ID: 23907773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report.
    Levis S; Theodore G
    J Manag Care Pharm; 2012 May; 18(4 Suppl B):S1-15; discussion S13. PubMed ID: 22716221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type 2 Diabetes Mellitus Increases the Risk to Hip Fracture in Postmenopausal Osteoporosis by Deteriorating the Trabecular Bone Microarchitecture and Bone Mass.
    Mohsin S; Kaimala S; Sunny JJ; Adeghate E; Brown EM
    J Diabetes Res; 2019; 2019():3876957. PubMed ID: 31815147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology and correlates of osteoporotic fractures among type 2 diabetic patients.
    Goldshtein I; Nguyen AM; dePapp AE; Ish-Shalom S; Chandler JM; Chodick G; Shalev V
    Arch Osteoporos; 2018 Mar; 13(1):15. PubMed ID: 29502187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.